Account
Inquiry
Tirzepatide 15mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently under investigation for metabolic applications. This synthetic peptide demonstrates superior efficacy in glucose control and weight management compared to single receptor agonists.
The tirzepatide 15mg formulation represents a significant advancement in peptide therapeutics, combining the beneficial effects of both GIP and GLP-1 pathways in a single molecule. Clinical studies have shown remarkable results, with the 15mg dose demonstrating superior metabolic effects in research models.
Research indicates that tirzepatide 15mg may offer advantages in both glycemic control and weight reduction applications. The dual mechanism of action provides synergistic benefits that are being actively investigated in scientific studies worldwide.
Our tirzepatide 15mg is produced under strict quality control standards, ensuring high purity and consistent performance in research applications. The product undergoes rigorous analytical testing to verify identity, purity, and potency.
Key features of our tirzepatide 15mg include: Pharmaceutical grade purity, lyophilized powder form, and stability under recommended storage conditions. The product is supplied in research quantities suitable for laboratory investigations.
For research purposes only. Not for human consumption. This product is intended for laboratory research by qualified professionals.
